SCOPUS 정보 검색 플랫폼

Volumn 7, Issue 6, 2012, Pages 1061-1063

Secondary resistance to erlotinib: Acquired T790M mutation and small-cell lung cancer transformation in the same patient

(9) Fallet, Vincent a Ruppert, Anne Marie a Poulot, Virginie a Lacave, Roger a,b Belmont, Laure a Antoine, Martine a Cadranel, Jacques a,b Wislez, Marie a,b Lavolé, Armelle a

a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS (France)

b SORBONNE UNIVERSITÉ (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; DOCETAXEL; ERLOTINIB; ETOPOSIDE; PACLITAXEL; PEMETREXED;

ADULT; ARTICLE; BRONCHIAL ASPIRATION PROCEDURE; BRONCHUS BIOPSY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EXON; FEMALE; FIBEROPTIC BRONCHOSCOPY; GENE DELETION; GENE MUTATION; HUMAN; LUNG ADENOCARCINOMA; LUNG LAVAGE; LUNG SMALL CELL CANCER; MALIGNANT TRANSFORMATION; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 84861306096 PISSN: 15560864 EISSN: 15561380 Source Type: Journal
DOI: 10.1097/JTO.0b013e31824fea45 Document Type: Article

Times cited : (24)

References (5)

1
- 22044445517
- Erlotinib in previously treated non-small-cell lung cancer
- DOI 10.1056/NEJMoa050753
- Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al.; National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-132. (Pubitemid 41058344)
- (2005) New England Journal of Medicine , vol.353 , Issue.2 , pp. 123-132
- Shepherd, F.A.¹ Pereira, J.R.² Ciuleanu, T.³ Eng, H.T.⁴ Hirsh, V.⁵ Thongprasert, S.⁶ Campos, D.⁷ Maoleekoonpiroj, S.⁸ Smylie, M.⁹ Martins, R.¹⁰ Van Kooten, M.¹¹ Dediu, M.¹² Findlay, B.¹³ Tu, D.¹⁴ Johnston, D.¹⁵ Bezjak, A.¹⁶ Clark, G.¹⁷ Santabarbara, P.¹⁸ Seymour, L.¹⁹

2
- 70349464846
- Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lungcancers dependent on the epidermal growth factor receptor pathway
- Nguyen KS, Kobayashi S, Costa DB. Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lungcancers dependent on the epidermal growth factor receptor pathway. Clin Lung Cancer 2009;10:281-289.
- (2009) Clin Lung Cancer , vol.10 , pp. 281-289
- Nguyen, K.S.¹ Kobayashi, S.² Costa, D.B.³

3
- 35748973894
- Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation
- DOI 10.1016/j.lungcan.2007.05.014, PII S0169500207003170
- Morinaga R, Okamoto I, Furuta K, et al. Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation. Lung Cancer 2007;58:411-413. (Pubitemid 350051499)
- (2007) Lung Cancer , vol.58 , Issue.3 , pp. 411-413
- Morinaga, R.¹ Okamoto, I.² Furuta, K.³ Kawano, Y.⁴ Sekijima, M.⁵ Dote, K.⁶ Satou, T.⁷ Nishio, K.⁸ Fukuoka, M.⁹ Nakagawa, K.¹⁰

4
- 79953118839
- Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
- Sequist LV, Waltman BA, Dias-Santagata D, et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 2011;3:75ra26.
- (2011) Sci Transl Med , vol.3
- Sequist, L.V.¹ Waltman, B.A.² Dias-Santagata, D.³

5
- 79955853698
- The LUX-Lung clinical trial program of afatinib for non-small-cell lung cancer
- Metro G Crinò L. The LUX-Lung clinical trial program of afatinib for non-small-cell lung cancer. Expert Rev Anticancer Ther 2011;11:673-682.
- (2011) Expert Rev Anticancer Ther , vol.11 , pp. 673-682
- Metro, G.¹ Crinò, L.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.